Osteosarcoma Recurrent Clinical Trial
Official title:
A Retrospective Observational Study of the Effectiveness of Gemcitabine -Docetaxel in Patients With Relapsed Osteosarcoma Who Have Been Treated With HD-IFO in First Line Treatment
A retrospective observational study of the effectiveness of gemcitabine - docetaxel in patients with relapsed osteosarcoma who have been treated with HD IFO in first line treatment
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03628209 -
Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma
|
Phase 1/Phase 2 | |
Completed |
NCT04651569 -
An Analysis of the Efficacy of High Dose Isofosfamide Through Elastomer
|
||
Recruiting |
NCT04417062 -
Olaparib With Ceralasertib in Recurrent Osteosarcoma
|
Phase 2 | |
Active, not recruiting |
NCT04803877 -
SARC038: Phase 2 Study of Regorafenib and Nivolumab in Osteosarcoma
|
Phase 2 | |
Not yet recruiting |
NCT06465199 -
Difluoromethylornithine (DFMO) and AMXT-1501 for Neuroblastoma, CNS Tumors, and Sarcomas
|
Phase 1/Phase 2 |